NasdaqGS - Delayed Quote
USD
Allogene Therapeutics, Inc. (ALLO)
1.9700
-0.0100
(-0.51%)
At close: September 4 at 4:00:01 PM EDT
1.9899
+0.0199
(+1.01%)
After hours: September 4 at 7:30:02 PM EDT
Trade ALLO on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for ALLO
What's happening with ALLO?
Powered by Yahoo ScoutAllogene Therapeutics is undergoing leadership changes with the retirement of CFO Geoffrey Parker and is actively participating in upcoming investor conferences. The company recently reported Q2 2026 earnings that beat estimates, driven by lower R&D costs and promising developments in its CAR T therapy pipeline.
Powered by Yahoo Scout
- Previous Close
1.9800 - Open
1.9500 - Bid 1.9900 x 100
- Ask 4.2500 x 100
- Day's Range
1.9500 - 2.0100 - 52 Week Range
1.0400 - 4.4600 - Volume
4,428,332 - Avg. Volume
7,436,690 - Market Cap (intraday)
680.617M - Beta (5Y Monthly) 0.48
- PE Ratio (TTM)
-- - EPS (TTM)
-0.6600 - Earnings Date Nov 5, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
9.00
Recent News
View More
Performance Overview
Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
ALLO
43.80%
S&P 500 (^GSPC)
12.75%
1-Year Return
ALLO
77.48%
S&P 500 (^GSPC)
18.71%
3-Year Return
ALLO
51.36%
S&P 500 (^GSPC)
70.93%
5-Year Return
ALLO
92.27%
S&P 500 (^GSPC)
70.18%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 9/1/2026
-
Market Cap
685.80M
-
Enterprise Value
423.55M
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
109.14
-
Price/Book (mrq)
1.58
-
Enterprise Value/Revenue
91.65
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-22.08%
-
Return on Equity (ttm)
-42.39%
-
Revenue (ttm)
4.64M
-
Net Income Avi to Common (ttm)
-165.49M
-
Diluted EPS (ttm)
-0.6600
Balance Sheet and Cash Flow
-
Total Cash (mrq)
332.6M
-
Total Debt/Equity (mrq)
18.11%
-
Levered Free Cash Flow (ttm)
-63.46M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Mkt Cap
undefined
-
Industry
-
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
